Click image to enlarge
The Kidney Injury Panel 3 (human) Kit provides the assay-specific components to measure calbindin, clusterin, HAVCR1/KIM-1 (hepatitis A virus cellular receptor 1; also known as kidney injury molecule-1 (KIM-1)), osteoactivin, trefoil factor 3 (TFF3), and vascular endothelial growth factor A (VEGF-A). This kit may be used for the analysis of these kidney injury biomarkers in human urine, serum, plasma, and cell supernatants.
| Analyte | LLOD - ULOD | units |
|---|
| Calbindin | 14 - 26,900 | pg/mL |
| Clusterin | 28 - 208,000 | pg/mL |
| HAVCR1/KIM-1 | 1.4 - 19,100 | pg/mL |
| Osteoactivin | 17 - 37,900 | pg/mL |
| TFF3 | 4.5 - 1,790 | pg/mL |
| VEGF-A | 0.20 - 2,180 | pg/mL |
-
-
Specifications
-
Kit Contents
-
Documentation
-
References
|
Application(s)
|
|
Kidney Injury
,
Toxicology
|
|
|
Analyte(s)
|
|
Calbindin, Clusterin, HAVCR1/KIM-1, Osteoactivin, TFF3, VEGF-A
|
|
|
Species
|
|
Human
|
|
|
Plate Type
|
|
96-well
|
|
|
Instrument(s)
|
|
MESO SECTOR S 600MM
,
MESO QuickPlex SQ 120MM
,
MESO SECTOR S 600
,
MESO QuickPlex SQ 120
,
SECTOR Imager 6000
,
SECTOR Imager 2400
|
|
|
Sample Type
|
|
Serum, Urine
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Storage Condition
|
|
Multi-Component
|
|
|
Schedule B Code
|
|
3822.19.0000
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Kidney Injury Panel 3 (human) 96-Well 10-Spot SECTOR Plate
|
2-8 °C
|
1 each
(1 each)
|
|
|
|
Kidney Injury Panel 3 (human) Calibrator Blend
|
≤-70 °C
|
1 vial
(1 vial)
|
|
|
|
SULFO-TAG Anti-human Clusterin Antibody
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
SULFO-TAG Anti-human HAVCR1/KIM-1 Antibody
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
SULFO-TAG Human VEGF-A Antibody
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
SULFO-TAG Anti-human Calbindin Antibody
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
SULFO-TAG Anti-human Osteoactivin Antibody
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
SULFO-TAG Anti-human TFF3 Antibody
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
|
≤-10 °C
|
1 bottle
(25 mL)
|
|
|
|
|
RT
|
1 bottle
(18 mL)
|
|
|
|
MSD Blocker A
|
RT
|
1 bottle
(250 mL)
|
|
|
|
MSD Phosphate Buffer
5X
|
RT
|
1 bottle
(50 mL)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Kidney Injury Panel 3 (human) 96-Well 10-Spot SECTOR Plate
|
2-8 °C
|
5 each
(1 each)
|
|
|
|
Kidney Injury Panel 3 (human) Calibrator Blend
|
≤-70 °C
|
5 vial
(1 vial)
|
|
|
|
SULFO-TAG Anti-human Clusterin Antibody
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
SULFO-TAG Anti-human HAVCR1/KIM-1 Antibody
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
SULFO-TAG Human VEGF-A Antibody
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
SULFO-TAG Anti-human Calbindin Antibody
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
SULFO-TAG Anti-human Osteoactivin Antibody
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
SULFO-TAG Anti-human TFF3 Antibody
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
|
≤-10 °C
|
1 bottle
(125 mL)
|
|
|
|
|
RT
|
1 bottle
(90 mL)
|
|
|
|
MSD Blocker A
|
RT
|
1 bottle
(250 mL)
|
|
|
|
MSD Phosphate Buffer
5X
|
RT
|
1 bottle
(50 mL)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Kidney Injury Panel 3 (human) 96-Well 10-Spot SECTOR Plate
|
2-8 °C
|
25 each
(1 each)
|
|
|
|
Kidney Injury Panel 3 (human) Calibrator Blend
|
≤-70 °C
|
25 vial
(1 vial)
|
|
|
|
SULFO-TAG Anti-human Clusterin Antibody
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
SULFO-TAG Anti-human HAVCR1/KIM-1 Antibody
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
SULFO-TAG Human VEGF-A Antibody
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
SULFO-TAG Anti-human Calbindin Antibody
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
SULFO-TAG Anti-human Osteoactivin Antibody
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
SULFO-TAG Anti-human TFF3 Antibody
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
|
≤-10 °C
|
5 bottle
(125 mL)
|
|
|
|
|
RT
|
5 bottle
(90 mL)
|
|
|
|
MSD Blocker A
|
RT
|
5 bottle
(250 mL)
|
|
|
|
MSD Phosphate Buffer
5X
|
RT
|
5 bottle
(50 mL)
|
|
|
|
Certificate of analysis
|
|
|
|
SDS
|
|
|
|
Title
|
Journal
|
Year
|
|
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection
|
|
|
|
Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial
|
|
|
|
Glyoxalase-1 overexpression reduces endothelial dysfunction and attenuates early renal impairment in a rat model of diabetes.
|
|
|
|
Urinary biomarkers track the progression of nephropathy in hypertensive and obese rats.
|
|
|
|
Application of emerging biomarkers of acute kidney injury in development of kidney-sparing polypeptide-based antibiotics.
|
|
|
|
|
View All
|
Order Details
back
K15756D
Catalog No
Size
Price in USD
Qty
K15756D-1
1 plate size
$2,422.00
K15756D-2
5 plate size
$10,265.00
K15756D-4
25 plate size
$46,196.00
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters